Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.
Department of Pediatric Pulmonology, School of Medicine, Universidad El Bosque, Bogota, Colombia.
Pediatr Pulmonol. 2021 Jun;56(6):1366-1373. doi: 10.1002/ppul.25342. Epub 2021 Mar 8.
Despite relatively recent advances in our understanding of the physiopathology of asthma and the availability of highly effective controller medications, such as inhaled corticosteroids (ICS), currently many pediatric patients fail to control their asthma, especially in low- and middle-income countries (LMICs). Although some of these difficult-to-control asthmatic children have severe therapy-resistant asthma, most of them experience poor asthma control due to various modifiable factors, among which poor adherence to inhaled controller therapy and inadequate inhaler technique are the most common. Although electronic monitoring devices have been considered to be essential tools in identifying patients with severe therapy-resistant asthma, their high cost and low availability have currently limited their use in clinical practice. For these reasons, clinicians might consider using validated self-reported questionnaires and the weight of inhaler canisters and as alternative and valid options for assessing adherence to inhaled controller therapy. Furthermore, clinicians might consider adopting validated instruments as an objective measurement of the adequacy of inhaler technique. Although recognizing poor adherence does not automatically lead to improved adherence, it is usually an essential first step in effectively targeting adherence behavior, especially if the reasons for low or erratic compliance are explored by means of non-judgmental doctor-patient communication. These recommendations could assist in overcoming our inability to have pediatric asthmatic patients use ICS and in avoiding escalating their controller therapy toward more expensive medications, eventually reaching the use biologics. Promoting the rational and cost-effective use of asthma controller therapy could help to optimize the limited health resources in many LMICs.
尽管我们对哮喘的病理生理学的理解以及高效的控制药物(如吸入皮质类固醇)的应用有了相对近期的进展,但目前许多儿科哮喘患者仍无法控制其哮喘,尤其是在低收入和中等收入国家(LMICs)。尽管其中一些难以控制的哮喘儿童患有严重的治疗抵抗性哮喘,但他们中的大多数由于各种可改变的因素而经历着较差的哮喘控制,其中包括吸入控制器治疗的依从性差和吸入器技术不足。尽管电子监测设备被认为是识别严重治疗抵抗性哮喘患者的重要工具,但由于其成本高且可用性低,目前在临床实践中限制了其使用。出于这些原因,临床医生可能会考虑使用经过验证的自我报告问卷和吸入器罐的重量作为评估吸入控制器治疗依从性的替代和有效选择。此外,临床医生可能会考虑采用经过验证的仪器作为评估吸入器技术充分性的客观测量方法。虽然认识到依从性差并不自动导致依从性的提高,但它通常是有效针对依从性行为的重要第一步,特别是如果通过非判断性的医患沟通来探讨低或不规则依从的原因。这些建议可以帮助克服我们无法让儿科哮喘患者使用 ICS 并避免将其控制器治疗升级为更昂贵的药物,最终达到使用生物制剂的问题。促进哮喘控制药物的合理和具有成本效益的使用,可以帮助优化许多 LMICs 有限的卫生资源。